Conversion to type1 diabetes after H1N1 influenza infection: A case report

Journal of Diabetes

Volumn 3, Issue 2, 2011, Pages 103-

  Watanabe, Nobuaki ^a  

^a Watanabe Medical Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE; INSULIN LISPRO; OSELTAMIVIR; DRUG DERIVATIVE; GLARGINE; INSULIN;

ADULT; CASE REPORT; DISEASE ASSOCIATION; DRUG DOSE INCREASE; HUMAN; INFLUENZA A (H1N1); INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; PRIORITY JOURNAL; INFLUENZA; INFLUENZA VIRUS A H1N1; METABOLISM; VIROLOGY;

ADULT; DIABETES MELLITUS, TYPE 1; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INSULIN; MALE; OSELTAMIVIR;

EID: 79956196744     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2010.00110.x     Document Type: Letter

References (3)

1. Infectious Disease Surveillance Center. Pandemic (H1N1) 2009. [In Japanese.]. Available from: (accessed 1 October 2010).
2. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979; 300: 1173-9.
3. Roman LM, Simons LF, Hammer RE, Sambrook JF, Gething MH. The expression of influenza virus hemagglutinin in the pancreatic βcell of transgenic mice result in autoimmune diabetes. Cell. 1990; 61: 383-96.